Health

Vinod Khosla has 3 predictions for the future of health. We’ve got 1 more

Above: Vinod Khosla, onstage at VentureBeat's DataBeat conference.

Image Credit: Michael O'Donnell

Vinod Khosla, sassy VC and legendary co-founder of Sun Microsystems, has predicted the future of health.

In essence, he has said, our medical lives will become increasingly automated, with ultra-intelligent systems prescribing fine-grain recommendations to nurse us back to health. According to a newly released report, he predicts:

1. 80 percent of what doctors do, diagnostics, will be replaced by machines
2. Medicine will become tailor-made for each patient
3. Consumer-driven tech will create better incentives to keep people healthy

For good measure, we think Khosla missed one important aspect of the future: we’ll move from disease care to actual health care. That is, thanks to pervasive monitoring, our goals won’t simply be to not be sick but to become the best person we can be.

A fidelity to science

“In the past, the data to make more rigorous and scientific conclusions has simply not been available,” reads Khosla’s most recent draft report [PDF].

“And as a result, medical literature is rife with studies about how the practice of medicine does not meet expectations for what would constitute sufficient, correct care.”

In one case, he notes, a major meta-analysis contradicted advice on the use of beta-blockers to prevent those at risk of stroke. “Despite being discredited, the AHA guideline has not been retracted as of 2013,” he concludes. The sheer volume of information is difficult to keep up with, even for the smartest doctors.

Smart diagnostic robots will able to apply the most advanced science to common problems. “That’s not to say 80 percent of doctors will go away. It’s that systems and consumers (directly) will handle 80 percent of their current work, so the role of the doctor will adapt dramatically to add value.”

In this case, think about IBM’s Jeopardy champion, Watson, which is already showing signs that it can diagnose cancer better than some doctors.

Tailor-made for you

Advanced manufacturing will combine with big data to make tailor-made recommendations and drug prescriptions.

“Data science will start to tell us how to measure the effectiveness of a particular drug for a particular patient’s specific conditions/genomics, environment/ethnicity, as opposed to the status quo of having drug companies develop one drug for all seven billion people on the planet,” Khosla predicts.

Doctors are already using genomic sequencing to target treatment more precisely. And chemists have tested existing 3D printers to replicate drugs. So, instead of all patients taking the same pill, measured out in oddly convenient integers, a home printer will delivery print a drug has precisely the amount of medicine you need.

Check out this TED talk on the subject:

Still, Khosla may have overlooked the controversial key needed to unlock this precision: public health data. In order to use all available health data collected, we have to combine health datasets. But combining that information has recently been used to re-identify anonymized data.

Consumer tech & better incentives

It is true that the Affordable Care Act (“Obamacare”) attempts to reward doctors for the outcomes of their patients, but that isn’t the case with the entire medical innovation industry.

Diagnostic devices are getting cheaper and cheaper; entrepreneurs may have different incentives to build tools that are both cheaper and more accurate, unlike hospitals.

“Medical device manufacturers, like those that build and sell huge scanning systems, don’t want to cannibalize sales of their expensive equipment by providing cheaper, more accessible monitoring devices, such as a $29 ECG monitor,” reads the report.

s4_front

Once expensive electrocardiograms can now fit on the back of an iPhone, Khosla continues, “Health insurance could give people similar financial rewards for improving their health and further making the consumer the CEO of his own health.”

Optimal health

Khosla’s otherwise fascinating look at the future of health has one important oversight: The overarching theme is still curing diseases, not optimizing health. The current health system assumes that as long as we’re not sick, there’s no reason to see a doctor.

But consumer devices are showing how improvements in meditation, nutrition, and exercise can make us each better versions of ourselves.

Computer-guided meditation headsets can already help novice yogis learn the amazing benefits of mindfulness. The upcoming Muse headband will be able to read our brain waves throughout the day. This available technology will soon able to show us how our eating and sleeping habits influence our stress and focus all day long.

The Jawbone Up, once a simple pedometer, now has an app to measure how caffeine intake affects our sleep. Very soon, we’ll be immersed in technology that can show us in real time how to feel as refreshed and energetic as we can possibly be. Once people get a taste, they’ll want even more.

Moreover, ocular wearables like Google Glass will be able to automatically analyze the nutritional content of food from a picture and then correlate that to weight gain measured by Internet-connected scales. We’ll know immediately what foods leave us drifting towards heart failure or vitamin deficiencies or closer to wellness and whole-body health.

Hybrid medical/sports startups, such as blood-diagnostics company WellnessFX, are beginning to cater to consumers who treat optimal living as their personal medical strategy. Genetrainer connects to genetics testing startup 23andMe and tells budding athletes how to optimize their regiment for their particular genes.

Optimal health, with any luck, will increasingly be part of the medical industry.

You can read Khosla’s very thorough forecast in this PDF.


HealthBeat — VentureBeat’s breakthrough health tech event — is returning on Oct 27-28 in San Francisco. This year’s theme is “The patient journey: Connections, data, and innovation.” We’re putting long-established giants of the health care world on stage with CEOs of the nation's most disruptive health tech companies to share insights, analyze trends, and showcase breakthrough products. Purchase your tickets now and save $100!
16 comments
Nik Fahreal
Nik Fahreal

Until he opens the beach, this issue will hound him

Taidista
Taidista

@VentureBeat there is a small error in your story. Interesting read. The PDF is even better.

Andrei Rînea
Andrei Rînea

The future of health is oblivion. Not even the mildest of the diseases can be reliably be cured. It's sad.

German Echeverry
German Echeverry

There is an error in your article. The meta-analysis you quote did not aim to "prevent those at risk of stroke" through beta blockade. Peri-operative beta blockade was intended to protect those at risk of serious CARDIAC events such as unstable angina and myocardial infarction (heart attack), not those at risk of stroke. Additionally, this meta-analysis is heavily influenced by data from one single study - the POISE trial (8,000 of the 10,000 patients come from this one study) which used MASSIVE and totally inappropriate doses of beta blockade on naive patients starting the day of surgery, something that is not mirrored in any other clinical setting. Not surprisingly, these patients had a higher risk of stroke and higher 30 day mortality (beta blockers lower blood pressure jeopardizing delivery of oxygen to the brain). Advocates of peri-operative beta blockade advise starting therapy up to a month prior to surgery, and with much more conservative doses of medication. Additionally, it is well demonstrated that withholding beta blockers also leads to increased mortality. I think this strengthens Vinod's point in that even our better than average data is still hugely flawed making it difficult to interpret. We desperately need a data revolution in medicine.

Filipa Padre
Filipa Padre

Big Pharma has a solution 'tailor made' for guys like you too

Stefanie Yang
Stefanie Yang

If medicine is being automated, what makes people think food production(GMO) isn't? Let's assume that is the case, doesn't it make more sense that corruption lies between agriculture and medicine companies that influences technology? Just saying...

Ted Kucklick
Ted Kucklick

The FDA dropped an anvil on the head of 23 and Me for making claims without the science, which is very expensive to do.

Michael Sinsheimer
Michael Sinsheimer

The jury is way out here, but it will be interesting to see how it all develops.  I'm certain it will develop in many unanticipated ways with associated unintended consequences.

Doug Millison
Doug Millison

Keep the beach open, nobody can own it in this state.